Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Ptc Therapeutics (PTCT)
Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,483,268
  • Shares Outstanding, K 74,191
  • Annual Sales, $ 698,800 K
  • Annual Income, $ -559,020 K
  • 60-Month Beta 0.43
  • Price/Sales 6.20
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PTCT with:

Options Overview Details

View History
  • Implied Volatility 60.45% ( -24.15%)
  • Historical Volatility 74.18%
  • IV Percentile 45%
  • IV Rank 31.55%
  • IV High 100.86% on 04/18/23
  • IV Low 41.83% on 12/06/22
  • Put/Call Vol Ratio 35.85
  • Today's Volume 10,576
  • Volume Avg (30-Day) 2,091
  • Put/Call OI Ratio 1.73
  • Today's Open Interest 27,891
  • Open Int (30-Day) 16,556

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -1.65
  • Number of Estimates 9
  • High Estimate -0.97
  • Low Estimate -3.04
  • Prior Year -2.13
  • Growth Rate Est. (year over year) +22.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.23 +11.18%
on 05/24/23
59.84 -21.54%
on 05/22/23
-5.90 (-11.16%)
since 04/24/23
3-Month
42.12 +11.47%
on 02/27/23
59.84 -21.54%
on 05/22/23
+3.71 (+8.58%)
since 02/24/23
52-Week
25.01 +87.72%
on 06/16/22
59.84 -21.54%
on 05/22/23
+15.59 (+49.71%)
since 05/24/22

Most Recent Stories

More News
Stocks Fall with U.S. Debt Ceiling Talks at an Impasse

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.90%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.08%....

$SPX : 4,115.24 (-0.73%)
SPY : 411.09 (-0.72%)
$DOWI : 32,799.92 (-0.77%)
DIA : 328.01 (-0.79%)
$IUXX : 13,604.48 (-0.50%)
QQQ : 331.65 (-0.51%)
A : 120.99 (-5.95%)
ADI : 173.20 (-7.83%)
MCHP : 73.62 (-5.15%)
NXPI : 166.52 (-4.88%)
GFS : 55.51 (-3.49%)
NVDA : 305.38 (-0.49%)
Markets Today: Stocks Decline as U.S. Debt Limit Talks Stall

Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are down -0.43%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.51%. U.S. stock index futures this morning are moderately lower...

ESM23 : 4,149.25 (+0.56%)
NQM23 : 13,902.75 (+1.85%)
A : 120.99 (-5.95%)
INTU : 415.92 (-7.53%)
ADI : 173.20 (-7.83%)
PLCE : 18.68 (-21.38%)
PLTR : 12.23 (-3.24%)
PTCT : 46.95 (-19.62%)
SITE : 141.26 (-4.60%)
PACW : 7.20 (-2.44%)
PANW : 204.31 (+7.68%)
VFC : 18.35 (-3.27%)
PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today reported topline results from the MOVE-FA trial of vatiquinone in patients with Friedreich ataxia....

PTCT : 46.95 (-19.62%)
PTC Therapeutics Announces Strategic Pipeline Prioritization

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the discontinuation of preclinical and early research programs in gene therapy as part of...

PTCT : 46.95 (-19.62%)
Chart of the Day: PTC Therapeutics (PTCT) Upgraded To Buy by Zacks

The Chart of the Day belongs to the biopharmaceutical company PTC Therapeutics (PTCT) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy...

PTCT : 46.95 (-19.62%)
PTC Therapeutics Announces APHENITY Trial Achieved Primary Endpoint with Sepiapterin in PKU Patients

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the primary endpoint was achieved in the APHENITY, Phase 3 registration-directed...

PTCT : 46.95 (-19.62%)
PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 24, 2023, the company approved non-statutory stock options to purchase an...

PTCT : 46.95 (-19.62%)
PTC Therapeutics: Q1 Earnings Snapshot

PTC Therapeutics: Q1 Earnings Snapshot

PTCT : 46.95 (-19.62%)
PTC Therapeutics Provides a Corporate Update and Reports First Quarter Financial Results

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and financial results for the first quarter ending March 31, 2023. "We...

PTCT : 46.95 (-19.62%)
PTC Therapeutics (PTCT) Upgraded to Buy: What Does It Mean for the Stock?

PTC Therapeutics (PTCT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PTCT : 46.95 (-19.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

See More

Key Turning Points

3rd Resistance Point 56.04
2nd Resistance Point 52.34
1st Resistance Point 49.64
Last Price 46.95
1st Support Level 43.24
2nd Support Level 39.54
3rd Support Level 36.84

See More

52-Week High 59.84
Last Price 46.95
Fibonacci 61.8% 46.53
Fibonacci 50% 42.42
Fibonacci 38.2% 38.32
52-Week Low 25.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar